genesis2015 q3 财报.pdf

FOR IMMEDIATE RELEASE Genesis HealthCare Contact: Investor Relations 610-925-2000 GENESIS HEALTHCARE REPORTS THIRD QUARTER 2015 RESULTS 1  Strong Third Quarter Performance and Growth With Pro Forma Adjusted: o EBITDAR of $188.8 Million, up 6.3% from Prior Year Quarter o EBITDA of $67.2 Million, up 13.1% from Prior Year Quarter o Diluted EPS of $0.07  Recent HUD Financing Approval Advances Balance Sheet Restructuring Initiatives; Expected to Improve Annual Free Cash Flow $25 - $30 Million KENNETT SQUARE, PA – (November 5, 2015) – Genesis HealthCare (Genesis, or the Company) (NYSE:GEN), one of the largest post-acute care providers in the United States, today announced operating results for the quarter and nine month periods ended September 30, 2015. Highlights  Previously announced expense reductions yield $10.2 million of savings in the third quarter and $25.7 million of savings through the first nine months of 2015; on track to realize $35 million in 2015;  Skilled Healthcare integration continues as planned; approximately $4.1 million of transaction synergies realized in the third quarter and $8.1 million through the first nine months of 2015; on track to realize $13 million in 2015;  Pro forma EBITDAR margins of approximately 13.4% grew 60 bps over the prior year quarter;  Genesis received formal portfolio credit approval from the U.S. Department of Housing and Urban Development Program (HUD);  Genesis’ planned acquisition of Revera Inc.’s 24 skilled nursing facilities and contract rehabilitation business is on track to close by year end, subject to regulatory and licensing